ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Curcumin: The All In One Solution, Part 2

CoQ10 — A Nutritional Powerhouse for Mitochondrial Health

What Are the Benefits of Vitamin K2?

Vitamin D deficiency + high fat diet = metabolic syndrome

Use Burdock Oil to Promote Healthy Hair Growth

Why You Should Take Your Apple Cider Vinegar at Night

AMA journal associates iron deficiency with hearing loss

Lutein linked to preservation of crystallized intelligence

People with forms of early-onset Parkinson's disease may benefit from boosting niacin in diet, resea...

Zinc eaten at levels found in biofortified crops reduces 'wear and tear' on DNA

 
Print Page
Email Article

Magnesium Sulfate To Mothers Just Prior To Delivery Of Preterm Babies May Improve Outcomes

  [ 144 votes ]   [ Discuss This Article ]
www.ProHealth.com • December 1, 2003


(Journal of the American Medical Association) -- Women who are given intravenous magnesium sulfate just before the birth of a very preterm baby may reduce the infant's risk of neurosensory impairments such as cerebral palsy, though this finding needs to be confirmed in other studies before it becomes standard practice, according to an article in the November 26 issue of The Journal of the American Medical Association (JAMA).

Infants born very preterm have increased risks of death or neurosensory impairments and disabilities such as cerebral palsy, according to background information in the article. Although other studies have suggested that use of prenatal magnesium sulfate may act as a neuroprotective agent for very preterm infants, there have been no large randomized controlled trials in which magnesium sulfate was given solely for neuroprotection.

Caroline A. Crowther, M.D., of The University of Adelaide, South Australia, and colleagues conducted a study to determine the effectiveness of magnesium sulfate in preventing pediatric death and/or cerebral palsy when given to women at risk of delivery before 30 weeks' gestation.

The study was a randomized controlled trial at 16 hospitals in Australia and New Zealand. It included 1,062 women with fetuses younger than 30 weeks' gestation for whom delivery was planned or expected within 24 hours. The participants were enrolled from February 1996 to September 2000 with follow-up of surviving children at 2 years of age. Women were randomly assigned to receive an intravenous infusion of magnesium sulfate solution or sodium chloride solution (as placebo) for 20 minutes followed by a maintenance infusion for up to 24 hours.

Data were analyzed for 1,047 (99 percent) 2-year survivors. "Total pediatric mortality (13.8 percent vs. 17.1 percent; [17 percent reduced risk]), cerebral palsy in survivors (6.8 percent vs. 8.2 percent; [17 percent reduced risk]), and combined death or cerebral palsy (19.8 percent vs. 24.0 percent; [17 percent reduced risk]) were less frequent for infants exposed to magnesium sulfate, but none of the differences were statistically significant. Substantial gross motor dysfunction (3.4 percent vs. 6.6 percent; [49 percent reduced risk]) and combined death or substantial gross motor dysfunction (17.0 percent vs. 22.7 percent; [25 percent reduced risk]) were significantly reduced in the magnesium group," the researchers write.

"The potential clinically important improvement in pediatric outcomes from magnesium sulfate given to women immediately before very preterm birth for neuroprotection urgently needs confirmation in further trials. Widespread use of prenatal magnesium sulfate as a neuroprotective agent cannot be recommended solely on the basis of the current study. Although minor adverse effects are common in women receiving magnesium sulfate, there do not appear to be any serious harmful effects for the women or their children," the authors write.



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor® Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Priming Your Immune System for Cold & Flu Season Priming Your Immune System for Cold & Flu Season
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia
Bone Broth Benefits for Digestion, Arthritis and Cellulite Bone Broth Benefits for Digestion, Arthritis and Cellulite
Running on Empty? Fuel Up with NADH Running on Empty? Fuel Up with NADH

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map